about
Comprehensive study of liposome-assisted synthesis of membrane proteins using a reconstituted cell-free translation system.Enhancement of anticancer effect of interferon-γ gene transfer against interferon-γ-resistant tumor by depletion of tumor-associated macrophages.Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.Contribution of Epigenetic Modifications to the Decline in Transgene Expression from Plasmid DNA in Mouse Liver.Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice.Long-term elimination of hepatitis C virus from human hepatocyte chimeric mice after interferon-γ gene transfer.Targeted Delivery of Interferon Gamma Using a Recombinant Fusion Protein of a Fibrin Clot-Binding Peptide With Interferon Gamma for Cancer Gene Therapy.Persistent interferon transgene expression by RNA interference-mediated silencing of interferon receptors.Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity.Inhibition of nuclear delivery of plasmid DNA and transcription by interferon γ: hurdles to be overcome for sustained gene therapy.Liposome chaperon in cell-free membrane protein synthesis: one-step preparation of KcsA-integrated liposomes and electrophysiological analysis by the planar bilayer method.[Control of spatiotemporal distribution of interferon γ by genetically fusing functional peptides].Proteoliposome Engineering with Cell-Free Membrane Protein Synthesis: Control of Membrane Protein Sorting into Liposomes by Chaperoning SystemsMembrane Protein Sorting: Proteoliposome Engineering with Cell-Free Membrane Protein Synthesis: Control of Membrane Protein Sorting into Liposomes by Chaperoning Systems (Adv. Sci. 10/2018)Expression profile-dependent improvement of insulin sensitivity by gene delivery of interleukin-6 in a mouse model of type II diabetes
P50
Q36371029-2592A77F-214B-4964-BC79-BB8E65E15CFEQ39007021-A6ADB1DF-523B-4B92-A803-5130EF4E4E5EQ39871943-2EBCCBA4-77F9-49B5-9CAD-EFBB570C6517Q41493998-68B4EB7F-E0BE-43BA-9894-7566BA364F88Q41987483-0B982FAE-C8A8-43E9-B210-5CD5EAF706B5Q42252888-8FC9B646-E072-416C-8E23-564279425595Q45862744-88851078-96C2-4264-80C8-BD83C4891B15Q45863384-AEB376ED-F831-4CDD-B65C-9E2DC9E6FE19Q45865862-E16AA32A-1388-4691-81BA-B04EBF32FA47Q45868915-179B267E-5E4D-4C35-8378-5AF778916AADQ51653716-E04CC8D8-179F-4F84-BA53-18456BB4F988Q53773971-1830FA8B-37FD-4CEE-A5BA-60C5E0623CC8Q57823583-8BE21FF6-2DBA-4489-A02B-11445C313C25Q58728560-1AD53EF9-90B2-40B0-A9F7-7F50277AB8ECQ86030446-577B01FA-8354-462D-938F-34BB3D69875A
P50
description
researcher ORCID ID = 0000-0001-8808-9713
@en
name
Mitsuru Ando
@ast
Mitsuru Ando
@en
Mitsuru Ando
@es
Mitsuru Ando
@nl
type
label
Mitsuru Ando
@ast
Mitsuru Ando
@en
Mitsuru Ando
@es
Mitsuru Ando
@nl
prefLabel
Mitsuru Ando
@ast
Mitsuru Ando
@en
Mitsuru Ando
@es
Mitsuru Ando
@nl
P108
P31
P496
0000-0001-8808-9713